U.S. Food and Drug Administration — Drug Shortages (FDA)

U.S. Food and Drug Administration — Drug Shortages is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.

Official register

www.accessdata.fda.gov

Country

United States

Notices tracked by Mederti

808

Last checked

2 Aug 2026

Latest notices from FDA

• Glycopyrrolate — active, medium, since 30 Jul 2026 (source)
• Doxycycline Hyclate — active, medium, since 30 Jul 2026 (source)
• Fluticasone Propionate; Salmeterol Xinafoate — active, medium, since 27 Jul 2026 (source)
• Lopinavir + Ritonavir — active, medium, since 24 Jul 2026 (source)
• Ritonavir — active, medium, since 24 Jul 2026 (source)
• Bendamustine-Hydrochloride — active, medium, since 23 Jul 2026 (source)
• Podophyllum — active, medium, since 23 Jul 2026 (source)
• Succinylcholine Chloride — active, critical, since 23 Jul 2026 (source)
• Belladonna Alkaloids (Hyoscyamine Sulfate — active, medium, since 23 Jul 2026 (source)
• Morphine — active, critical, since 23 Jul 2026 (source)
• Hydromorphone Hydrochloride — active, medium, since 23 Jul 2026 (source)
• Hydrocortisone-Hydrogen-Succinate — active, medium, since 23 Jul 2026 (source)
• Aspirin — active, medium, since 23 Jul 2026 (source)
• Dextrose Monohydrate 5% — active, critical, since 20 Jul 2026 (source)
• Tobramycin — active, medium, since 17 Jul 2026 (source)

Mederti is not affiliated with or endorsed by U.S. Food and Drug Administration — Drug Shortages. All notices remain the property of their publisher and are linked to the original source.